Quarterly report pursuant to Section 13 or 15(d)

Revenue and Accounts Receivable (Tables)

v3.4.0.3
Revenue and Accounts Receivable (Tables)
3 Months Ended
Mar. 31, 2016
Receivables [Abstract]  
Schedule of Revenue by Service Type
Revenue by service type for the three months ended March 31, 2016 and 2015 is comprised of the following (in thousands): 
 
Three Months Ended March 31,
 
2016
 
2015
Biopharma Services
$
3,350

 
$
3,331

Clinical Services
2,456

 
873

Discovery Services
262

 
166

 
$
6,068

 
$
4,370

Schedule of Accounts Receivable by Service Type
Accounts receivable by service type at March 31, 2016 and December 31, 2015 consists of the following (in thousands): 

March 31,
2016
 
December 31,
2015
Biopharma Services
$
3,334

 
$
3,238

Clinical Services
5,432

 
3,733

Discovery Services
347

 
314

Allowance for doubtful accounts
(664
)
 
(664
)

$
8,449

 
$
6,621


Allowance for Doubtful Accounts (in thousands)
Balance, December 31, 2015
$
664

Additions to allowance for doubtful accounts

Balance, March 31, 2016
$
664

Schedule of Clinical Services Revenue (As a Percent of Total Revenue)
The breakdown of our Clinical Services revenue (as a percent of total revenue) is as follows:

 
Three Months Ended March 31,
 
2016
 
2015
Medicare
15%
 
6%
Other insurers
21%
 
7%
Other healthcare facilities
4%
 
7%
 
40%
 
20%